Publication | Closed Access

ANTIBODY-DRUG SYNERGISM: AN ASSESSMENT OF SPECIFIC PASSIVE IMMUNOTHERAPY IN BRONCHIAL CARCINOMA

Cancer ImmunosurveillanceMedicineImmunologyImmune Checkpoint InhibitorBronchial NeoplasmCancer TreatmentLung CancerImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentAntibody-drug Synergism